Page last updated: 2024-08-25

5-hydroxymethylcytosine and Benign Neoplasms, Brain

5-hydroxymethylcytosine has been researched along with Benign Neoplasms, Brain in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's11 (78.57)24.3611
2020's3 (21.43)2.80

Authors

AuthorsStudies
Cao, F; Hu, X; Liu, Y; Mao, Q; Xia, L; Xie, D; Yan, X; Yan, Z; Yin, S; Yuan, Y; Zhang, J; Zhang, S1
Li, C; Li, P; Li, S; Liu, P; Niu, Y; Tong, WM; Wang, B; Wu, T; Yang, Z; Zhang, J; Zhang, ZW; Zhao, F1
Aldape, K; Farooq, H; Glowacka, WK; Jain, H; Kongkham, P; Maimaitiming, A; Mamatjan, Y; Nejad, R; Okura, M; Taylor, MD1
Ding, Y; Fu, R; Guo, SW; Huang, KM; Li, DS; Luo, J; Tang, XJ1
Cain, JE; Jayasekara, WSN; St John, JC; Sun, X; Vaghjiani, V1
Astudillo, A; Bayón, GF; Bigot, T; Carella, A; Chiara, MD; Corte-Torres, MD; Fernández, AF; Fraga, MF; García, MG; García-Toraño, E; López, V; Mangas, C; Meléndez, B; Mollejo, M; Pérez, RF; Sáenz-de-Santa-María, I; Santamarina-Ojeda, P; Sierra, M; Tejedor, JR; Urdinguio, RG1
Li, L; Ye, C1
Akiyama, T; Ino, Y; Katou, Y; Koyama-Nasu, R; Kozuka-Hata, H; Masuda, K; Morishita, Y; Mukasa, A; Nasu-Nishimura, Y; Ogawa, H; Oyama, M; Saito, N; Sakaguchi, Y; Sato, T; Shirahige, K; Suzuki, T; Takai, H; Todo, T; Toyoshima, C1
Kriaucionis, S; McClellan, M; Schuster-Boeckler, B; Tomkova, M1
Cui, Y; Freeman, JL; Irudayaraj, J; Li, J; Liu, J; Liu, Q; Weng, L; Wirbisky, SE; Yuan, X1
Christensen, BC; Fadul, CE; Houseman, EA; Johnson, KC; King, JE; von Herrmann, KM1
Jiang, Y; Jin, SG; Krex, D; Lu, Q; Pfeifer, GP; Qiu, R; Rauch, TA; Schackert, G; Wang, Y1
Carell, T; Eigenbrod, S; Feiden, W; Globisch, D; Hackner, B; Kraus, TF; Kretzschmar, HA; Müller, M; Münzel, M; Pfaffeneder, T; Schüller, U; Wagner, M; Widmann, D1
Becker, A; Denkhaus, D; Freihoff, D; Freihoff, J; Gessi, M; Hammes, J; Isselstein, LJ; Luxen, D; Müller, T; Pietsch, T; Simon, M; Waha, A; zur Mühlen, A1

Reviews

1 review(s) available for 5-hydroxymethylcytosine and Benign Neoplasms, Brain

ArticleYear
5-hydroxymethylcytosine: a new insight into epigenetics in cancer.
    Cancer biology & therapy, 2014, Volume: 15, Issue:1

    Topics: 5-Methylcytosine; Animals; Brain Neoplasms; Cytosine; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Humans; Leukemia; Mixed Function Oxygenases; Neoplasms; Proto-Oncogene Proteins

2014

Other Studies

13 other study(ies) available for 5-hydroxymethylcytosine and Benign Neoplasms, Brain

ArticleYear
Noninvasive detection of brain gliomas using plasma cell-free DNA 5-hydroxymethylcytosine sequencing.
    International journal of cancer, 2023, 04-15, Volume: 152, Issue:8

    Topics: 5-Methylcytosine; Brain; Brain Neoplasms; Glioma; Humans; Isocitrate Dehydrogenase; Mutation

2023
Characterization of global 5-hydroxymethylcytosine in pediatric posterior fossa ependymoma.
    Clinical epigenetics, 2020, 01-28, Volume: 12, Issue:1

    Topics: 5-Methylcytosine; Adolescent; Brain Neoplasms; Carcinogenesis; Case-Control Studies; Cell Proliferation; Child; Child, Preschool; DNA Methylation; Ependymoma; Epigenomics; Female; Humans; Infant; Infratentorial Neoplasms; Ki-67 Antigen; Male; Prognosis; Proportional Hazards Models

2020
5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma.
    Acta neuropathologica, 2018, Volume: 135, Issue:4

    Topics: 5-Methylcytosine; Adult; Aged; Brain Neoplasms; Cohort Studies; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Glioma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Neoplasm Grading; RNA, Messenger; Up-Regulation

2018
Ten-eleven translocation 1 regulates methylation of autophagy-related genes in human glioma.
    Neuroreport, 2018, 06-13, Volume: 29, Issue:9

    Topics: 5-Methylcytosine; Autophagy; Brain; Brain Neoplasms; Cell Line, Tumor; DNA Methylation; Glioma; Humans; Mixed Function Oxygenases; Neoplasm Grading; Proto-Oncogene Proteins

2018
The degree of mitochondrial DNA methylation in tumor models of glioblastoma and osteosarcoma.
    Clinical epigenetics, 2018, 12-17, Volume: 10, Issue:1

    Topics: 5-Methylcytosine; Animals; Bone Neoplasms; Brain Neoplasms; Cell Line, Tumor; DNA Copy Number Variations; DNA Methylation; DNA, Mitochondrial; Genotype; Glioblastoma; Humans; Immunoprecipitation; Mice; Mitochondria; Neoplasm Transplantation; Osteosarcoma; Whole Genome Sequencing

2018
Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis.
    International journal of cancer, 2020, 01-15, Volume: 146, Issue:2

    Topics: 5-Methylcytosine; Animals; Biopsy; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Dioxygenases; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Glioblastoma; Histone Code; Humans; Mice; Prognosis; RNA, Messenger; Survival Analysis; Xenograft Model Antitumor Assays

2020
5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex.
    Cell reports, 2014, Oct-09, Volume: 9, Issue:1

    Topics: 5-Methylcytosine; Acetylation; Brain Neoplasms; Carcinogenesis; Chromatin; Cytosine; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Glioblastoma; HEK293 Cells; Histones; Humans; Methylation; Mixed Function Oxygenases; Nuclear Proteins; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins; Repressor Proteins; Transcription Factors; Transcription, Genetic

2014
5-hydroxymethylcytosine marks regions with reduced mutation frequency in human DNA.
    eLife, 2016, 05-16, Volume: 5

    Topics: 5-Methylcytosine; Brain Neoplasms; CpG Islands; Databases, Genetic; DNA Methylation; DNA, Neoplasm; Epigenesis, Genetic; Exome Sequencing; Humans; Kidney Neoplasms; Mutation Rate; Myelodysplastic Syndromes; Myeloid Cells

2016
Regulatory landscape and clinical implication of MBD3 in human malignant glioma.
    Oncotarget, 2016, Dec-06, Volume: 7, Issue:49

    Topics: 5-Methylcytosine; Brain Neoplasms; Cell Line, Tumor; Disease-Free Survival; DNA-Binding Proteins; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glioma; High-Throughput Nucleotide Sequencing; HLA-D Antigens; Humans; MicroRNAs; Oligonucleotide Array Sequence Analysis; Pilot Projects; RNA Interference; RNA, Long Noncoding; RNA, Untranslated; Signal Transduction; Time Factors; Transcription, Genetic; Transfection

2016
5-Hydroxymethylcytosine localizes to enhancer elements and is associated with survival in glioblastoma patients.
    Nature communications, 2016, 11-25, Volume: 7

    Topics: 5-Methylcytosine; Adult; Aged; Aged, 80 and over; Brain Neoplasms; DNA Methylation; DNA, Neoplasm; Enhancer Elements, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Glioblastoma; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Prefrontal Cortex; Survival Analysis; Transcription Factors

2016
5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations.
    Cancer research, 2011, Dec-15, Volume: 71, Issue:24

    Topics: 5-Methylcytosine; Animals; Base Sequence; Brain; Brain Neoplasms; Carcinoma, Squamous Cell; Cell Line, Tumor; Chromatography, Liquid; Cytosine; DNA-Binding Proteins; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Lung Neoplasms; Male; Mice; Mixed Function Oxygenases; Molecular Structure; Mutation; Neoplasms; Proto-Oncogene Proteins; Reverse Transcriptase Polymerase Chain Reaction

2011
Low values of 5-hydroxymethylcytosine (5hmC), the "sixth base," are associated with anaplasia in human brain tumors.
    International journal of cancer, 2012, Oct-01, Volume: 131, Issue:7

    Topics: 5-Methylcytosine; Adolescent; Adult; Aged; Aged, 80 and over; Anaplasia; Astrocytoma; Brain; Brain Neoplasms; Cerebral Cortex; Child; Child, Preschool; Cytosine; DNA; Epigenesis, Genetic; Female; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Young Adult

2012
Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
    The American journal of pathology, 2012, Volume: 181, Issue:2

    Topics: 5-Methylcytosine; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Cytosine; Dioxygenases; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; DNA-Binding Proteins; Dual-Specificity Phosphatases; Female; Gene Expression Regulation, Enzymologic; Glioblastoma; Glioma; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Male; Mitogen-Activated Protein Kinase Phosphatases; Mixed Function Oxygenases; Mutation; Proto-Oncogene Proteins; Real-Time Polymerase Chain Reaction; RNA, Messenger; Sequence Analysis, DNA; Subcellular Fractions; Tumor Suppressor Proteins

2012